This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

DVT

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Deep vein thrombosis, a subset of venous thromboembolism (VTE), occurs in normal veins, usually the deep calf veins of the leg and propagates more proximally (1).

  • it may also affect other sites such as the upper limbs, intracranial and splanchnic veins (2)
  • anatomically, it can be divided as
  • proximal DVT
    • involves popliteal vein and proximal veins
    • around 80% of DVTs
  • distal DVT
    • involves calf vein and distal veins (3)
  • the disease is often asymptomatic, but 1 per 1,000 people/year in the general population presents with clinical symptoms (2)

It is generally thought of as a complication of surgery or illness.

  • surveillance data have revealed that the absolute risk of DVT in general medical patients is 10%-20% while it increases to 40%-80% in patients having hip surgery, knee surgery, or major trauma (4)

However, a number of situations predispose an individual to a deep vein thrombosis, and are encapsulated in Virchow's Triad (blood hypercoagulability, endothelial damage and venous stasis) (4).

The natural history is one of gradual breakdown of the thrombus with recanalisation. Damage to the valves may produce deep venous incompetence.

DVT is a usual precursor of both fatal PE and post-thrombotic syndrome (PTS) (4).

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.